MYD88 and Alzheimer disease: In addition, FMT in transgenic AD mouse models reduced inflammation via the TLR4-Myeloid differentiation factor 88 (MyD88)-NF-κB (TLR4/MyD88/NF-κB) pathway and increased SCFA production (67).